Study investigates risk when discontinuing therapy for MS patients over 55
An article published in the The Lancet Neurology journal evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.
Jun 23, 2023
0
30